niacinamide has been researched along with Central Nervous System Neoplasm in 2 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with sorafenib and HDAC inhibitors radio-sensitized both GBM and medulloblastoma cell lines." | 1.38 | Sorafenib and HDAC inhibitors synergize to kill CNS tumor cells. ( Dent, P; Grant, S; Hamed, HA; Poklepovic, A; Tang, Y; Tye, G; Yacoub, A, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salloum, R | 1 |
| Hummel, TR | 1 |
| Kumar, SS | 1 |
| Dorris, K | 1 |
| Li, S | 1 |
| Lin, T | 1 |
| Daryani, VM | 1 |
| Stewart, CF | 1 |
| Miles, L | 1 |
| Poussaint, TY | 1 |
| Stevenson, C | 1 |
| Goldman, S | 1 |
| Dhall, G | 1 |
| Packer, R | 1 |
| Fisher, P | 1 |
| Pollack, IF | 1 |
| Fouladi, M | 1 |
| Boyett, J | 1 |
| Drissi, R | 1 |
| Tang, Y | 1 |
| Yacoub, A | 1 |
| Hamed, HA | 1 |
| Poklepovic, A | 1 |
| Tye, G | 1 |
| Grant, S | 1 |
| Dent, P | 1 |
1 trial available for niacinamide and Central Nervous System Neoplasm
| Article | Year |
|---|---|
A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study.
Topics: Adolescent; Alanine Transaminase; Antineoplastic Agents; Blood Cell Count; Central Nervous System Ne | 2016 |
1 other study available for niacinamide and Central Nervous System Neoplasm
| Article | Year |
|---|---|
Sorafenib and HDAC inhibitors synergize to kill CNS tumor cells.
Topics: Antineoplastic Agents; Benzenesulfonates; Cell Line, Tumor; Cell Survival; Central Nervous System Ne | 2012 |